tiprankstipranks
Intelligent Bio Solutions Submits FDA Premarket Notification
Company Announcements

Intelligent Bio Solutions Submits FDA Premarket Notification

Story Highlights

Stay Ahead of the Market:

Intelligent Bio Solutions ( (INBS) ) just unveiled an update.

Intelligent Bio Solutions Inc. has submitted a 510(k) premarket notification to the FDA for its Intelligent Fingerprinting Drug Screening System, a non-invasive and rapid drug testing method. This submission marks a significant step toward entering the US market, offering opportunities for growth and establishing the company as a leader in non-invasive testing solutions across various industries.

More about Intelligent Bio Solutions

Intelligent Bio Solutions Inc. is a medical technology company specializing in innovative, rapid, non-invasive testing solutions. They focus on fingerprint sweat analysis for drug screening, targeting industries like construction, transportation, and logistics, as well as law enforcement and drug rehabilitation sectors.

YTD Price Performance: -65.83%

Average Trading Volume: 142,431

Technical Sentiment Consensus Rating: Buy

Current Market Cap: $6.07M

Learn more about INBS stock on TipRanks’ Stock Analysis page.

Related Articles
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App

Latest News Feed

More Articles